ZELMAC 6mg tablets medication leaflet

A03AE02 tegaserod • Alimentary tract and metabolism | Drugs for functional gastrointestinal disorders | Serotonin receptor antagonists

Tegaserod is a partial 5-HT4 receptor agonist used for the treatment of irritable bowel syndrome with constipation (IBS-C) in women and chronic idiopathic constipation. It stimulates intestinal motility and increases fluid secretion in the intestine, thereby alleviating symptoms.

The medication is taken orally, usually twice daily before meals, as directed by a doctor. It is important for patients to follow the prescribed dosage and inform the doctor of any unusual symptoms.

Patients should be aware of potential side effects, such as abdominal pain, diarrhea, or nausea. It is important to inform the doctor of any unusual symptoms.

Common side effects include abdominal pain, diarrhea, nausea, and dizziness. In rare cases, severe reactions such as intestinal ischemia or allergic reactions may occur. Patients should be informed of these risks before starting treatment.

General data about ZELMAC 6mg

Substance: tegaserod

Date of last drug list: 01-07-2013

Commercial code: W12737001

Concentration: 6mg

Pharmaceutical form: tablets

Quantity: 30

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Other substances similar to tegaserod